Solasta Bio
EMEA
Glasgow
,
United Kingdom
Scaleup
FOUNDED
2020
HEADCOUNT
21-100
FUNDING
Series A
Keywords:
crop_protection
BUSINESS
Founded in 2020 in Glasgow, Scotland, spun out of the University of Glasgow. Solasta Bio develops peptide-based bioinsecticides derived from insect neuropeptides that target specific pest species while remaining non-toxic to pollinators, wildlife, and humans. Field trials across 20 sites in the UK, Europe, and US demonstrated efficacy matching or exceeding commercial synthetic insecticides. The company has US operations in North Carolina and is targeting market entry in 2027
BIOTECH INVOLVEMENT
Solasta Bio uses a peptide discovery platform to identify and develop small neuropeptide-based insect control agents with species-specific modes of action. The peptides are nature-inspired (based on insect signaling molecules) and designed to be biodegradable with no environmental accumulation.
TECHNOLOGY PLATFORM
peptide-based bioinsecticides
PRIMARY PRODUCTS
Precision-targeted bioinsecticides